Risk for Tattoo-Related Complications in Patients With Psoriasis
Researchers investigated the risk for tattoo-related complications among patients with psoriasis.
Pruritus
Historic Management and Emerging Therapies for Atopic Dermatitis
Clinicians review traditional and emerging treatments for atopic dermatitis in the pediatric population, as well as insights from their own experiences.
Favorable Benefit-Risk Profile for Upadacitinib for the Long-Term Treatment of Atopic Dermatitis
The efficacy and safety of upadacitinibin for the long-term treatment of atopic dermatitis is assessed.
More Study of Systemic Therapies for Atopic Dermatitis Needed in Patients With Comorbidities
Expert treatment recommendations for patients with atopic dermatitis and comorbidities are reviewed.
Persistent Cutaneous Symptoms in Patients With “Long COVID”
The effects of “long COVID” on the skin are reviewed.
Reducing Surgical Excision Scar Formation
The efficacy of skin tension reduction device (SWTRD) plus ablative fractional carbon dioxide laser (CO2-AFL) for preventing facial scar formation in children is assessed.
Cutaneous Adverse Effects Common With Enfortumab Vedotin for Urothelial Cancer
Researchers described dermatologic events associated with the use of enfortumab vedotin in treatment of locally advanced/metastatic urothelial cancer.
Sleep Disturbance Highly Prevalent in Psoriasis Patients
Strongest predictors of sleep impairment include anxiety and depression levels, pruritus exacerbation at night, in morning
Tapinarof Reduces Severity of Plaque Psoriasis
The findings from 2 identical phase 3 trials that assessed the safety and efficacy of tapinarof 1% cream for plaque psoriasis are reviewed.
Seborrheic Dermatitis and Systemic Inflammation
The role of systemic inflammation in the etiopathogenesis of seborrheic dermatitis (SD) and the correlation between inflammatory markers and SD severity are assessed.
- Loading...
Loading...
Next post in Dermatitis
Loading... 
Loading...